맨위로

The World Leading Biopharmaceutical Company

Expert of Cell Therapeutics
for Brain Diseases
Core
Competency
01
Vision

Biomedical Company with world best technologies

About us →

02
Technologies

To create the most valuable therapy using human stem cells

MSC → NSC →

03
Therapeutics

To offer novel cell therapeutics to patients with brain diseases

Overview →

Pipeline
Overview →
Newsroom
more →
Press Release
익산시, ㈜메디노와 투자협약 체결
img

2024.06.10

Press Release
\'국가대표 바이오 스타트업\' 21개사 선정
img

2024.05.24

Press Release
조선대, 메디노와 뇌혈관 및 신경계 질환 치료제 개발 MOU
img

2024.05.09

Press Release
메디노 조산아 희귀질환 치료제 후보물질, 中 홍쉥사이언스에 기술이전
img

2024.01.16

Press Release
Cytonus Therapeutics Enters Licensing Agreement with Medinno for HIEstem™, a Neuro-Regenerative Cell
img

2024.01.09

Press Release
韓·美 바이오벤처, 신약 후보물질·플랫폼 기술 첫 상호 협력
img

2023.12.19

(08513) Room 820, The Reason Valley, 66 Gasan-ro-9-gil, Geumcheon-gu, Seoul, South Korea

Copyright © MEDINNO Inc. All Rights Reserved.